Suppr超能文献

[宫颈上皮内瘤变的诊断与分级]

[Diagnosis and grading of cervical intraepithelial neoplasias].

作者信息

Rosamilia C, Feichter G, Tzankov A, Obermann E C

机构信息

Institut für Pathologie, Universitätsspital Basel, Schönbeinstr. 40, 4031, Basel, Schweiz.

出版信息

Pathologe. 2012 Mar;33(2):118-23. doi: 10.1007/s00292-011-1549-5.

Abstract

Diagnosing and grading of cervical intraepithelial neoplasias (CIN) are part of the routine practice of pathologists. However, discriminating between reactive changes and CIN1 and determining the different degrees of CIN may be challenging. Aim of this study was the evaluation of the proliferation markers Ki-67 and Mcm2 as well as p16 for their potential to aid in the assessment of CIN. 297 samples of normal epithelium, CIN1, CIN2, and CIN3 were assessed for expression of the above mentioned markers using tissue microarrays. There was an increase in the expression of Ki67 and Mcm2 from normal epithelium, CIN1, CIN2 to CIN3 (p<0.001 for both markers). Ki-67 was the most useful marker in differentiating between normal epithelium and CIN1. The number of p16-positive cases was 7% in CIN1, 46% in CIN2 and 86% in CIN3. There were no p16-positive cases in the group with normal epithelium. In order to grade CIN1 vs. CIN2 a combination of Ki-67 and p16 was helpful. Cases with a proliferation rate of <25% assessed with Ki-67 were most likely CIN1 (sensitivity 91.7%, specificity: 54.3%, positive predictive value: 73.3%, negative predictive value 82.6%). P16 was the most helpful marker in distinguishing between CIN2 and CIN 3 as p16 negative cases were more likely to belong into the CIN2 category. In summary, the histopathological assessment of cervical biopsies is based on H&E-stained slides. However, Ki-67 and p16 can be helpful in diagnosing and grading cervical intraepithelial neoplasia.

摘要

宫颈上皮内瘤变(CIN)的诊断与分级是病理学家日常工作的一部分。然而,区分反应性改变与CIN1以及确定CIN的不同程度可能具有挑战性。本研究的目的是评估增殖标志物Ki-67和Mcm2以及p16在辅助评估CIN方面的潜力。使用组织微阵列对297份正常上皮、CIN1、CIN2和CIN3样本进行上述标志物表达的评估。从正常上皮、CIN1、CIN2到CIN3,Ki67和Mcm2的表达均增加(两种标志物的p均<0.001)。Ki-67是区分正常上皮和CIN1最有用的标志物。CIN1中p16阳性病例数为7%,CIN2中为46%,CIN3中为86%。正常上皮组中无p16阳性病例。为了对CIN1与CIN2进行分级,Ki-67和p16的联合使用很有帮助。用Ki-67评估增殖率<25%的病例最可能为CIN1(敏感性91.7%,特异性:54.3%,阳性预测值:73.3%,阴性预测值82.6%)。p16是区分CIN2和CIN 3最有用的标志物,因为p16阴性病例更可能属于CIN2类别。总之,宫颈活检的组织病理学评估基于苏木精-伊红染色切片。然而,Ki-67和p16有助于宫颈上皮内瘤变的诊断和分级。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验